AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitanat M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Natco Pharma Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitanat M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of cardiovascular events like stroke or heart attack. Combiflex DM 50mg/500mg may be administered as a standalone therapy or in conjunction with other anti-diabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glucose levels, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when used with insulin or sulfonylureas; prompt recognition and treatment are essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, as well as significant alcohol consumption. Pregnant or lactating women should consult their doctor. Interactions with other medications are possible; disclose all concurrent medications for safety evaluation. Alcohol should be minimized due to its potential to lower blood glucose. Your physician will monitor kidney function and blood sugar levels throughout the treatment period.

Primary Ingredients of Sitanat M 50mg/500mg Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Sitanat M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sitanat M 50mg/500mg Tablet:

Administer this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sitanat M 50mg/500mg Tablet with a meal.

Common Side effects of Sitanat M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitanat M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 50mg/500mg Sitanat M Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitanat M 50mg/500mg Tablet works:

Sitanat M 50mg/500mg tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitanat M 50mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitanat M 50mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitanat M 50mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitanat M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Sitanat M 50mg/500mg tablet use. Physician consultation is essential. Routine kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Sitanat M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitanat M 50mg/500mg Tablet :

Should you forget a Sitanat M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitanat M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitanat M 50mg/500mg Tablet

Sitanat M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitanat M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Sitanat M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Sitanat M 50mg/500mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitanat M 50mg/500mg Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitanat M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitanat M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitanat M 50mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Sitanat M 50mg/500mg Tablet components or excipients should not use it. This medication is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitanat M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitanat M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitanat M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitanat M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitanat M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitanat M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitanat M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitanat M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), and other complications. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitanat M 50mg/500mg Tabl...
119
MRP 138
13% off